Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Will the Medical Technology Evolution Excel Next Year?

Healthcare is constantly evolving in an effort to keep our world functioning. As a society we have come a long way since the days of archaic methods such as bloodletting and radium therapy. However, while these practices seem bizarre and frightening today, those innovations taught medical scientists much about the role of blood in the…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Healthcare is constantly evolving in an effort to keep our world functioning. As a society we have come a long way since the days of archaic methods such as bloodletting and radium therapy. However, while these practices seem bizarre and frightening today, those innovations taught medical scientists much about the role of blood in the body’s functioning as well as the early potential for radiation and electricity that is used in some modern-day treatments. Without pushing the envelope in medicine, it is unlikely that we would have vaccines for polio and influenza or cures for common infections. Today, new forward-thinking innovations are at the brink of solving this generation’s problems.

Every day, more than 115 Americans succumb to opioid addictions by way of fatal overdose. Considered by some to be the worst drug-addiction epidemic in our country’s history, this problem currently costs the American public about $78.5 billion per year. After many years of trial and error, now there is hope for those suffering with chronic pain. Pharmacogenomic testing can now predict through an individual’s genetic signature how he or she will metabolize and react to certain drugs, including those with an opiate base. The goal is to tailor medication therapies based on genetic makeup. In 2019, pharmacogenomics is poised to make significant inroads into precision medicine and potentially an end to the crisis.

Similar to pharmacogenomic testing is the advent of cancer immunotherapy, in which the body’s own internal workings also can be used in a positive way. Such advancements are critical in the healthcare industry, since the National Institute of Health estimated that in 2018, approximately 1,735,350 new cases of cancer would be diagnosed in the United States and 609,640 people would die from the disease. With immunotherapy, also called biologic therapy, the immune system itself is used to fight cancer cells. With continual discoveries in cancer research, scientists are hopeful that effective therapies will soon exist for all tumor profiles.

And finally, technologies are in development that will have a broad impact on physician care in every specialty. One such innovation is the use of virtual and mixed reality to educate medical professionals on the most cutting-edge research in their areas of expertise as well as general medicine. These programs are growing in popularity and provide simulation training that cannot replace traditional education but certainly enhances it. Importantly, VR/MR training appeals to all types of learners: audio, visual, and kinesthetic. The goal is to increase knowledge and confidence across the medical industry in a manner that almost every medical professional will find attractive.

The Occupational Outlook Handbook predicts that the need for healthcare occupations will grow by 18 percent between 2016 to 2026, adding about 2.4 million new jobs. This growth is anticipated to be the largest among all professional industries and is likely a result of an aging population. With these numbers in mind, innovations in health care will become even more important over the next decade.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @HealthMKSL

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512